EPOC Share Price

Open 11.74 Change Price %
High 11.75 1 Day -0.02 -0.17
Low 11.73 1 Week 0.00 0.00
Close 11.73 1 Month 0.00 0.00
Volume 569737 1 Year 0.00 0.00
52 Week High 16.61
52 Week Low 10.50
EPOC Important Levels
Resistance 2 11.75
Resistance 1 11.74
Pivot 11.74
Support 1 11.72
Support 2 11.71
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
MU 20.45 7.29%
MU 20.45 7.29%
MU 20.45 7.29%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
ANTH 2.03 38.10%
EMKR 8.45 31.01%
MBLX 0.32 28.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
HTCO 8.00 23.08%
ATEA 1.95 21.88%
ATEA 1.95 21.88%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
QKLS 0.12 -36.84%
More..

Epocrates, Inc. (NASDAQ: EPOC)

EPOC Technical Analysis 5
As on 11th Mar 2013 EPOC Share Price closed @ 11.73 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 9.34 & Strong Buy for SHORT-TERM with Stoploss of 11.16 we also expect STOCK to react on Following IMPORTANT LEVELS.
EPOC Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
EPOC Other Details
Segment EQ
Market Capital 229301728.00
Sector Technology EDP Services
Industry
Offical website
EPOC Address
EPOC
N/A
EPOC Latest News
Epocrates Is #1, Again   GlobeNewswire (press release)   - 06th Jul 15
Epocrates Must Face Investors' Suit Over Financial Disclosures   Law360 (subscription)   - 17th Mar 15
Epocrates Ranked #1 Top Medical Reference App Among US Physicians   HIT Consultant   - 10th Jun 14
AthenaHealth Acquires Epocrates, the Angry Birds of Healt   Bloomberg   - 07th Jan 13
Multimedia Release -- Epocrates' Prescription for Medical App Overload is Here   GlobeNewsWire (press release)   - 28th Oct 11
Department of Defense and Epocrates Provide Clinicians With Convenient Access ...   GlobeNewsWire (press release)   - 31st Mar 11
Epocrates Prices IPO Above Range   Seeking Alpha   - 04th Feb 11
Epocrates, Inc. Appoints Former Pfizer Executive Peter Brandt to Board of ...   Business Wire (press release)   - 03rd Feb 11
Epocrates Announces Acquisition of Modality   Business Wire (press release)   - 17th Nov 10
Epocrates Introduces Interactive CME Offering for Clinicians   Business Wire (press release)   - 10th Nov 10
Interactive Technical Analysis Chart Epocrates, Inc. ( EPOC NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Epocrates, Inc.
EPOC Business Profile
Epocrates, Inc. (Epocrates) is a provider of mobile drug reference tools and electronic health records to healthcare professionals and interactive services to the healthcare industry. As of December 31, 2011, its user network consists of well over one million healthcare professionals, including approximately 340,000, or more than 50% of United States physicians. The Company offers its products on major United States mobile platforms, including Apple iOS, Android and BlackBerry. Epocrates operates in two segments: Subscriptions and Interactive Services, and Electronic Health Records. It uses brand names include DocAlert, Epocrates, Epocrates Honors, Epocrates ID, Epocrates Lab, Epocrates MedTools, Epocrates Rx, Epocrates Rx Pro, Epocrates Dx, Epocrates QuickSurvey, Epocrates QuickRecruit, Epocrates MedInsight, EssentialPoints and MedCafe. In October 2011, it launched a redesign of the drug reference tool to create a new platform that provides healthcare professionals.